Related Experiment Video
Updated: Jun 22, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Risk Factors for Heart Failure Readmission After Cardiac Surgery
Sharif A Sabe1, Marwa A Sabe2, Kevin F Kennedy3
1Division of Cardiothoracic Surgery, Department of Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Insights
Identifying risk factors for heart failure (HF) readmissions after cardiac surgery is crucial. Older age, female sex, and certain comorbidities like chronic kidney disease increase HF readmission risk post-surgery.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Heart failure (HF) is a significant cause of readmission following cardiac surgery.
- Risk factors for HF readmission after cardiac surgery are not well understood.
Purpose of the Study:
- To identify risk factors for 30-day HF-specific readmissions after cardiac surgery.
- Utilize a national database for comprehensive risk factor analysis.
Main Methods:
- Analysis of the 2016-2018 National Readmissions Database.
- Inclusion of patients undergoing coronary artery bypass grafting (CABG) or valve surgery.
- Multivariable logistic regression to identify independent risk factors for HF readmission.
Main Results:
- 394,050 patients included; 7,318 (approx. 1.85%) had 30-day HF readmissions.
- Independent risk factors: older age, female sex, prolonged stay, congestive HF, CKD, COPD, liver disease, obesity, AFib, AKI.
- Prior CABG showed a protective effect against HF readmission.
Conclusions:
- Identified key demographic and clinical risk factors for 30-day HF readmission post-cardiac surgery.
- Further research is needed to explore these associations and inform interventions.
Background:
Heart failure (HF) is a leading cause of readmission after cardiac surgery, yet risk factors for HF readmission after cardiac surgery remain poorly characterized.
Objectives:
This study aimed to identify risk factors associated with 30-day HF-specific readmissions after cardiac surgery using a national database.
Methods:
We queried the 2016 to 2018 National Readmissions Database to identify U.S. patients who underwent coronary artery bypass grafting (CABG), mitral valve repair/replacement, and/or aortic valve repair/replacement. Exclusion criteria included history of ventricular assist device or heart transplant, dialysis-dependent renal insufficiency, and death during index admission. Clinical variables were defined using International Classification of Diseases-10th Revision codes. The primary outcome was a 30-day readmission for HF following discharge. Multivariable logistic regression was used to account for relevant clinical and demographic covariates and identify independent risk factors for HF readmissions following cardiac surgery.
Results:
Our study included 394,050 patients who underwent cardiac surgery (mean age 66 ± 12 years, 63% isolated CABG, 27% isolated valve, 11% CABG + valve). Of these patients, 7,318 were readmitted within 30 days of discharge for a principal diagnosis of HF. Independent risk factors of HF-specific readmission included older age, female sex, prolonged length of stay, comorbid congestive HF, nondialysis dependent chronic kidney disease, chronic obstructive pulmonary disease, chronic liver disease, obesity, atrial fibrillation, and acute kidney injury. Prior CABG was marginally protective for HF-specific readmission.
Conclusions:
Using a national registry, we identified risk factors associated with HF readmission after cardiac surgery. Further analysis of these risk factors and their association with HF readmission is warranted.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents

